
Focus on Agentic AI startups that build vertical-specific tools to automate industry functions, as this is the next evolution of the SaaS business model. Investors should prioritize healthcare companies like Eli Lilly (LLY) and Novo Nordisk (NVO) that are bypassing traditional middlemen to sell drugs directly to consumers. Be cautious of general-purpose humanoid robotics companies, as specialized, environment-optimized hardware is expected to outperform human-shaped designs over the next decade. Monitor the infrastructure sector for opportunities in 5G and satellite bandwidth, which are critical bottlenecks for the next generation of video-based AI models. Avoid small, unbranded e-commerce "widget" businesses on Amazon (AMZN) due to high risks of intellectual property theft and tax advantages held by international sellers.
Mark Cuban identifies "agents for everything" as the primary trend in early-stage startups. He views this as the evolution of the SaaS (Software as a Service) model.
Cuban holds a contrarian, bearish view on the current trend of humanoid (human-shaped) robots.
Cuban’s primary business focus is disrupting the pharmaceutical and healthcare insurance industry through radical transparency.
Cuban highlights a significant structural disadvantage for American sellers on the Amazon platform.
While not the main focus, Cuban touched on the intersection of AI and crypto.
Cuban shared his personal experience with Tesla's Full Self-Driving (FSD) technology.

By John Coogan & Jordi Hays
Technology's daily show (formerly the Technology Brothers Podcast). Streaming live on X and YouTube from 11 - 2 PM PST Monday - Friday. Available on X, Apple, Spotify, and YouTube.